Robyn Pm Saw
Overview
Explore the profile of Robyn Pm Saw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li A, Xu J, Blah T, Lo S, Saw R, Varey A, et al.
J Am Acad Dermatol
. 2024 Sep;
92(1):58-67.
PMID: 39243946
Background: Melanoma is increasingly recognized as a heterogeneous disease, with conflicting evidence regarding whether cutaneous head and neck melanoma (CHNM) represents a distinct entity. Objective: Comparison of clinicopathological features and...
2.
Drabarek D, Habgood E, Ackermann D, Hersch J, Janda M, Morton R, et al.
JMIR Dermatol
. 2023 Aug;
5(4):e40623.
PMID: 37632906
Background: The growing number of melanoma patients who need long-term surveillance increasingly exceeds the capacity of the dermatology workforce, particularly outside of metropolitan areas. Digital technologies that enable patients to...
3.
Holmberg C, Ny L, Hieken T, Block M, Carr M, Sondak V, et al.
Eur J Cancer
. 2022 Jun;
169:210-222.
PMID: 35644725
Purpose: Guidelines addressing melanoma in-transit metastasis (ITM) recommend immune checkpoint inhibitors (ICI) as a first-line treatment option, despite the fact that there are no efficacy data available from prospective trials...
4.
Thompson J, Smith A, Lo S, Kasparian N, Saw R, Dieng M, et al.
BMJ Open
. 2022 Mar;
12(3):e054337.
PMID: 35241467
Introduction: Fear of cancer recurrence (FCR) is commonly reported by patients diagnosed with early-stage (0-II) melanoma and can have a significant impact on daily functioning. This study will pilot the...
5.
El Sharouni M, Scolyer R, van Gils C, Chng S, Nieweg O, Pennington T, et al.
Eur J Cancer
. 2022 Feb;
167:133-141.
PMID: 35216870
Introduction: This study sought to assess whether the interval between diagnostic excision-biopsy of a primary melanoma and definitive wide excision with sentinel node biopsy (SNB) influenced the size of SN...
6.
Pennington T, Zhao C, Colebatch A, Fernandez-Penas P, Guitera P, Burke H, et al.
Australas J Dermatol
. 2022 Feb;
63(2):e133-e137.
PMID: 35188271
Background: Immune checkpoint inhibitors have improved survival in advanced stage melanoma patients. Rates of new primary melanomas (NPM) in patients with prior melanoma have been reported to be as high...
7.
Hanna S, Lo S, Saw R
Eur J Surg Oncol
. 2021 Mar;
47(7):1558-1574.
PMID: 33722422
Background: The main treatment of primary cutaneous melanoma is surgery. This review aims to assess the width of excision margin that minimises the risk of adverse outcome from surgery, locoregional...
8.
Shklovskaya E, Lee J, Lim S, Stewart A, Pedersen B, Ferguson P, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33202676
Immunotherapy targeting T-cell inhibitory receptors, namely programmed cell death-1 (PD-1) and/or cytotoxic T-lymphocyte associated protein-4 (CTLA-4), leads to durable responses in a proportion of patients with advanced metastatic melanoma. Combination...
9.
Watts C, Smith A, Robinson S, Chang C, Goumas C, Schmid H, et al.
Aust J Gen Pract
. 2020 May;
49(6):355-362.
PMID: 32464734
Background And Objectives: In Australia, the uptake of the sentinel lymph node biopsy (SLNB) appears low despite clinical practice guideline recommendations. The aim of this study was to describe the...
10.
Harris C, Lo S, Ahmed T, Scolyer R, Ferguson P, Karim R, et al.
Eur J Surg Oncol
. 2020 May;
46(11):2131-2139.
PMID: 32417156
Purpose: Primary dermal melanoma (PDM) is a subtype of cutaneous melanoma, confined to the dermis, which poses a challenging clinical dilemma. It may represent a true primary melanoma or a...